February 2024 Statewide Webinar: Reserve Your Spot!

Fatty Liver Disease: A Silent Epidemic

Wednesday, February 28, 2024

12 - 1 p.m. ET



1.0 CME credit offered at no cost.

KEYNOTE SPEAKER

Lanla F. Conteh, MD, MPH, MBA

The Ohio State University

OBJECTIVES

• Screen and identify patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
• Describe current disparities in care in MASLD risk, assessment, and management.
• Manage contributing risk factors to MASLD in patient care.
• Counsel patients on current risks, treatment options, and prognosis.

Tune in to Cardi-OH Radio

Podcast 41 - Managing Heart Failure Risk in Your Patient With Hypertension and Diabetes

Listen to Ian Neeland, MD, from Case Western Reserve University.

Cardi-OH Radio podcasts highlight national, state, and local leaders discussing timely topics for primary care clinicians. 

Want to be the first to know when a podcast is released? Subscribe to our channel. 

Pearls for Clinical Practice

Capsule 40 - Facilitating Behavior Change With Consumer Wearable Devices

Did You Know?

While consumer wearable devices collect many cardiac and extra cardiac metrics, evidence for the interpretation and application of the data in the clinical setting is still emerging. Consumer wearable devices may support physical activity and goal setting as a part of patient care.



Capsules provide busy clinicians brief summaries of best practices that are ready to be implemented in clinical care.

News You Can Use

Current 35 - USPSTF Recommends Regular BP Measurements to Screen for Hypertensive Disorders of Pregnancy

Currents provide brief summaries of the latest advances in medicine or clinical practice related to diabetes or hypertension and include links to additional resources.